One Stop Shop For Reports One Stop Shop For Reports
  • All Reports
  • All Sectors
    • Chemicals & Materials
      • Advanced Materials
      • Bulk Chemicals
      • Coatings | Paints and Additives
      • Composites
      • Renewable | Speciality chemicals
    • Consumer Goods
      • Baby Products
      • Consumer Electronics
      • Consumer Packaging
      • Cosmetics & Personal Care
      • Homecare & Decor
      • Luxury & premium products
    • Energy and Power
      • Energy Efficiency and Conservation
      • Green | Renewable Energy
      • Non Renewable | Conventional Energy
      • Power Equipment and Devices
    • Life Science
      • Biotechnology
      • Diagnostics
      • Healthcare
      • Healthcare IT
      • Medical Devices & Supplies
      • Pharmaceuticals
    • Food and Beverage
      • Agriculture & Agri Products
      • Beverages
      • Food Ingredients
      • Food Services and Hospitality
      • Nutraceutical | Wellness Food
      • Processed & Frozen Foods
    • Automotive and Transportation
      • Automotive components
      • Automotive Logistics
      • Automotive systems and accessories
    • Information and Communications Technology
      • E Commerce and Outsourcing
      • Entertainment & Media
      • High Tech | Enterprise & Consumer IT
      • Information & Network Security
      • Mobility | Telecom & Wireless
      • Software and Services
    • Semiconductor and Electronics
      • Semiconductor Materials and Components
      • Display Technology
      • Electronics System and Components
      • Emerging technologies
      • Security and Surveillance
      • Sensors and Controls
    • Building and Construction
      • Construction Materials
      • HVAC
      • Residential Construction and Improvement
      • Roads & Highways
    • Manufacturing
      • Manufacturing Services
      • Heavy Manufacturing
      • Packaging
      • Engineering | Equipment and Machinery
  • Who Trust Us
  • [email protected]
  • +1 718 874 1545 (International)
  • +91 78878 22626 (Asia)

More Results

One Stop Shop For Reports One Stop Shop For Reports
  • All Reports
  • All Sectors
    • Chemicals & Materials
      • Advanced Materials
      • Bulk Chemicals
      • Coatings | Paints and Additives
      • Composites
      • Renewable | Speciality chemicals
    • Consumer Goods
      • Baby Products
      • Consumer Electronics
      • Consumer Packaging
      • Cosmetics & Personal Care
      • Homecare & Decor
      • Luxury & premium products
    • Energy and Power
      • Energy Efficiency and Conservation
      • Green | Renewable Energy
      • Non Renewable | Conventional Energy
      • Power Equipment and Devices
    • Life Science
      • Biotechnology
      • Diagnostics
      • Healthcare
      • Healthcare IT
      • Medical Devices & Supplies
      • Pharmaceuticals
    • Food and Beverage
      • Agriculture & Agri Products
      • Beverages
      • Food Ingredients
      • Food Services and Hospitality
      • Nutraceutical | Wellness Food
      • Processed & Frozen Foods
    • Automotive and Transportation
      • Automotive components
      • Automotive Logistics
      • Automotive systems and accessories
    • Information and Communications Technology
      • E Commerce and Outsourcing
      • Entertainment & Media
      • High Tech | Enterprise & Consumer IT
      • Information & Network Security
      • Mobility | Telecom & Wireless
      • Software and Services
    • Semiconductor and Electronics
      • Semiconductor Materials and Components
      • Display Technology
      • Electronics System and Components
      • Emerging technologies
      • Security and Surveillance
      • Sensors and Controls
    • Building and Construction
      • Construction Materials
      • HVAC
      • Residential Construction and Improvement
      • Roads & Highways
    • Manufacturing
      • Manufacturing Services
      • Heavy Manufacturing
      • Packaging
      • Engineering | Equipment and Machinery
  • Who Trust Us
Home ➤ Companies ➤ Pfizer Inc Company Profile

Pfizer Inc Company Profile

Pfizer Inc

Pfizer Inc

Biopharmaceutical Industry

  • Type

    Public

  • Headquarters

    The US

  • Establishment

    1849

  • Key Management

    Mr. Albert Bourla (CEO)

  • Revenue (MnUS$)

    ~ 81,288 (2021)

  • Headcount

    ~ 79,000 (2021)

  • Website

    www.pfizer.com

Business Description

Pfizer Inc. is a global biopharmaceutical company based on research, is Pfizer Inc. It is involved in the development, manufacturing, marketing, sales, and distribution of biopharmaceutical products worldwide. It works in emerging and developed markets to improve wellness, prevention, treatment, and cures for the most dangerous diseases. Charles Pfizer Sr., Charles Erhart, and the company’s headquarters are in New York, NY. Pfizer UK, the main subsidiary of multinational pharmaceutical company Pfizer, is in the United Kingdom.

 

Key Financials

 

Revenue (US$ Mn)

 

  • US$ 81,288 Mn was the annual revenue generated by Pfizer Inc in 2021
  • Pfizer Inc’s annual revenue for 2020 was US$ 41,908 Mn, a -19.02% decrease from 2019
  • From 2018’s annual revenues, Pfizer Inc registered a -3.54% decrease in 2019, amounting to US$ 51,750 Mn
  • Total revenue of US$ 53,647 Mn was generated in 2018 by Pfizer Inc

 

Operating Income (US$ Mn)

 

  • Pfizer Inc’s operating income for 2021 was US$ 20,235 Mn, a 130.99% increase from 2020
  • The operating income generated by Pfizer Inc in 2020 was US$ 8,760 Mn
  • At a -7.47% decrease, Pfizer Inc’s operating income of US$ 13,921 Mn was indexed in 2019
  • Pfizer Inc generated an operating income of US$ 15,045 Mn in 2018

 

 Net Income (US$ Mn)

 

  • US$ 21,979 Mn was Pfizer Inc’s net income in 2021, a 128.57% increase from 2020 figures
  • Pfizer Inc indexed a -40.91% decrease in net incomes from 2019, amounting to US$ 9,616 Mn in 2020
  • Pfizer Inc generated a net income of US$ 16,273 Mn in 2019
  • A net income of US$ 11,153 Mn was indexed by Pfizer Inc in 2018

 

Operating Margin %

 

  • 25% was the operating margin generated by Pfizer Inc in 2021
  • Pfizer Inc’s operating margin for 2020 was 21%, a -22.3% decrease from 2019
  • From 2018’s operating margins, Pfizer Inc registered a -3.93% decrease in 2019, amounting to 27%
  • An operating margin of 28% was generated in 2018 by Pfizer Inc

 

Gross Margin %

 

  • Pfizer Inc’s gross margin for 2021 was 62%, a -21.69% decrease from 2020
  • The gross margin generated by Pfizer Inc in 2020 was 79%
  • At a 1.65% increase, Pfizer Inc’s gross margin of 80% was indexed in 2019
  • Pfizer Inc generated a gross margin of 79% in 2018

 

SWOT Analysis

Strengths

Robust research and development capabilities

Pfizer’s research and development (R&D) activities focus on developing new models for biomedical collaboration, delivering a pipeline of differentiated therapies and vaccines, and advancing its capabilities. The company’s R&D team focuses on developing innovative medicines in the areas of Internal Medicine, Vaccines, Oncology, Rare Diseases, Biosimilars, Inflammation, and Immunology. It conducts R&D internally and also through collaborations with universities and biotechnology companies, through contracts with third parties, and in cooperation with other pharmaceutical firms.

In FY2019, the company had 95 projects in clinical research and development, including 26 in Phase I; 37 in Phase II, 23 in Phase III, and nine in the registration phase. Pfizer operates its R&D facilities in North America and planning to operationalize the new facilities in Saint Louis, Missouri, and Massachusetts. In FY2019, the company spent US$8,650 million on R&D, which accounted for 16.7% of the company’s revenue. Thus, strong R&D capabilities help the company to bring new, innovative products to market, which in turn enables Pfizer to secure a competitive advantage.

 

Get this premium content

The Premium data is Locked
Buy Now to Unlock Premium Data

Table of Content

  1. Business Description
  2. Key Financials
  3. SWOT Analysis
    1. Strength
      1. Robust research and development capabilities
      2. Business performance of innovative health segment
      3. Operational Performance
    2. Weakness
      1. Revenue
    3. Opportunities
      1. Positive outlook for global pharmaceuticals market
      2. Product approvals to strengthen Pfizer’s portfolio
      3. Strategic collaborations and agreements
    4. Threats
      1. Healthcare reforms and drug pricing controls likely to affect the company's operating margin
      2. Consolidation among managed care organizations
      3. Influx of generics
    5. Key Developments
      1. Year 2021
      2. Year 2020
      3. Year 2019
  • US $299
  • US $499
Buy Now
✖

Request For Company Data

We'll get back to you as quickly as possible

Primary Sidebar

  • location_on420 Lexington Avenue, Suite 300 New York City, NY 10170,
    United States
  • phone+1 718 874 1545 (International)
  • phone+91 78878 22626 (Asia)
  • email[email protected]
  • Facebook Logo
  • Twitter Logo
  • LinkedIn Logo
Find Help
  • Contact Us
  • How to Order
Legal
  • Privacy Policy
  • Refund Policy
  • Frequently Asked Questions
  • Terms and Conditions
Explore
  • About Us
  • All Reports
  • All Sectors
  • Infographics
  • Statistics and Facts
  • Companies
Secured Payment Options
Secured Payment Options

© 2025 Market.Us. All Rights Reserved.